Chronic lymphocytic leukaemia
Top Cited Papers
Open Access
- 21 February 2018
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 391 (10129), 1524-1537
- https://doi.org/10.1016/s0140-6736(18)30422-7
Abstract
No abstract availableThis publication has 136 references indexed in Scilit:
- Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximabLeukemia, 2013
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765Blood, 2011
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemiaNature, 2011
- Pentostatin and rituximab therapy for previously untreated patients with B‐cell chronic lymphocytic leukemiaCancer, 2010
- Validation of a new prognostic index for patients with chronic lymphocytic leukemiaCancer, 2009
- Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemiaBlood, 2008
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Respiratory tract infections and subsequent risk of chronic lymphocytic leukemiaBlood, 2006
- Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemiaBlood, 2006